Xorte logo

News Markets Groups

USA | Europe | Asia | World| Stocks | Commodities



Add a new RSS channel

 
 


Keywords

2023-03-28 02:31:01| The Economic Times

The current valuations of Reliance do not assume any value for its new energy and new commerce businesses, foray into the fast-moving consumer goods business, while reflecting investor concerns around the growing debt in the company, slow growth in the retail business and a rise in the capital expenditure, said analysts.


Category: News and Media

 

Latest from this category

02.06UK: Is An Employer Liable For The Acts Of A Third Party? - Weightmans
02.06United States: ESI Protocols: Courts Hold Parties To Account For Failing To Comply With The Protocols They Negotiated - K&L Gates
02.06India: Taxation Of A Non-resident Vol 1 - ALMT Legal
02.06United States: Seven Things To Know About The SRC Public Float Measurement Date And SRC Qualification - Goodwin Procter LLP
02.06United States: The New Age Of Trust And Estate Planning With Tim Jordan (Video) - Fairfield and Woods
02.06Malta: Efficiencies And Improvements That KYC Portal Can Bring To Your Operations - Finance Malta
02.06United States: The Week In Weed: May 26, 2023 - Seyfarth Shaw LLP
02.06United States: Alvotech And Advanz Pharma Extend Partnership To Commercialize Five Proposed Biosimilars In Europe - Goodwin Procter LLP
News and Media »

All news

02.06UK: Is An Employer Liable For The Acts Of A Third Party? - Weightmans
02.06United States: ESI Protocols: Courts Hold Parties To Account For Failing To Comply With The Protocols They Negotiated - K&L Gates
02.06India: Taxation Of A Non-resident Vol 1 - ALMT Legal
02.06United States: Seven Things To Know About The SRC Public Float Measurement Date And SRC Qualification - Goodwin Procter LLP
02.06United States: The New Age Of Trust And Estate Planning With Tim Jordan (Video) - Fairfield and Woods
02.06Malta: Efficiencies And Improvements That KYC Portal Can Bring To Your Operations - Finance Malta
02.06United States: The Week In Weed: May 26, 2023 - Seyfarth Shaw LLP
02.06United States: Alvotech And Advanz Pharma Extend Partnership To Commercialize Five Proposed Biosimilars In Europe - Goodwin Procter LLP
More »
Privacy policy . Copyright . Contact form .